Press Availability -- AAAS Forum On Human Germ-Line Interventions

Thursday, September 25
AAAS Headquarters, 1200 New York Ave., N.W.
12:15 p.m. - 1:00 p.m.
Abelson Conference Room second floor

The following participants of the AAAS Forum on Human Germ-line Interventions will be available to answer questions from the media following the conclusion of the forum (names and titles are followed by the title of the sessions in which they will participate):

• Theodore Friedmann, M.D., University of California, San Diego, "Scientific Overview"
• Erik Parens, Ph.D., The Hastings Center, "Therapeutic vs. Enhancement Applications"
• Claudia Mickelson, Ph.D., Chair, NIH Recombinant DNA Advisory Committee, "Setting Policy and Developing Guidelines"
• Ronald Cole-Turner, Ph.D., Pittsburgh Theological Seminary, "Ethical and Theological Issues"

Reporters attending the forum or the press availability are required to RSVP to Dave Amber, 202-326-6434, or send an email to damber@aaas.org.

AAAS FORUM ON HUMAN GERM-LINE INTERVENTIONS

Scientists, ethicists, policymakers, and theologians will consider implications of human germ-line intervention at a first-of-its-kind public forum sponsored by the American Association for the Advancement of Science (AAAS).

The forum will be held on Wednesday, September 24 from 9:00 a.m. to 8:30 p.m., and Thursday, September 25 from 9:00 a.m. to noon at the AAAS headquarters, 1200 New York Ave., NW (Metro Station: MetroCenter, red, orange or blue lines). Members of the public must RSVP to Robert Bobala, 202-326-6733, or send an email to rbobola@aaas.org.

##